NovelMed Therapeutics

NovelMed Therapeutics is a cutting-edge clinical-stage biotechnology company developing novel therapies for orphan and non-orphan diseases, with a particular focus on blocking certain parts of the immune system involved in disease processes. With its unique portfolio of neutralizing monoclonal antibodies, NovelMed is targeting chronic conditions with significant market potential and unmet medical needs.